Actively Recruiting
Spanish Decision Tool for Ovarian Cancer Maintenance Therapy
Led by M.D. Anderson Cancer Center · Updated on 2026-04-16
70
Participants Needed
1
Research Sites
217 weeks
Total Duration
On this page
Sponsors
M
M.D. Anderson Cancer Center
Lead Sponsor
M
Merck Sharp & Dohme LLC
Collaborating Sponsor
AI-Summary
What this Trial Is About
To develop a shared decision-making (SDM) tool to help Spanish-speaking patients make decisions about their maintenance therapy
CONDITIONS
Official Title
Spanish Decision Tool for Ovarian Cancer Maintenance Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals 18 years or older with advanced stage high grade epithelial ovarian, fallopian tube, or primary peritoneal cancer
- Patients who are receiving or have completed platinum-based chemotherapy for ovarian cancer and are potentially eligible for maintenance therapy
- Ability to understand, speak, or read Spanish
- MD Anderson gynecologic oncologists and advanced practice providers practicing at Houston Area Locations, MD Anderson Cancer Center, or The Harris Health System (LBJ Hospital)
You will not qualify if you...
- Inability or unwillingness to sign informed consent for participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
L
Larissa Meyer, M D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here